[PDF][PDF] SARS-CoV-2 variants B. 1.351 and P. 1 escape from neutralizing antibodies
The global spread of SARS-CoV-2/COVID-19 is devastating health systems and economies
worldwide. Recombinant or vaccine-induced neutralizing antibodies are used to combat the …
worldwide. Recombinant or vaccine-induced neutralizing antibodies are used to combat the …
[HTML][HTML] Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent …
R Groß, M Zanoni, A Seidel, C Conzelmann, A Gilg… - …, 2022 - thelancet.com
Background Heterologous COVID-19 vaccination regimens combining vector- and mRNA-based
vaccines are already administered, but data on solicited adverse reactions, …
vaccines are already administered, but data on solicited adverse reactions, …
[HTML][HTML] Robust and durable serological response following pediatric SARS-CoV-2 infection
H Renk, A Dulovic, A Seidel, M Becker… - Nature …, 2022 - nature.com
The quality and persistence of children’s humoral immune response following SARS-CoV-2
infection remains largely unknown but will be crucial to guide pediatric SARS-CoV-2 …
infection remains largely unknown but will be crucial to guide pediatric SARS-CoV-2 …
[HTML][HTML] Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
SARS-CoV-2 is a respiratory pathogen and primarily infects the airway epithelium. As our
knowledge about innate immune factors of the respiratory tract against SARS-CoV-2 is limited, …
knowledge about innate immune factors of the respiratory tract against SARS-CoV-2 is limited, …
[HTML][HTML] COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models
The COVID-19 pandemic caused by SARS-CoV-2 has made the development of safe and
effective vaccines a critical priority. To date, four vaccines have been approved by European …
effective vaccines a critical priority. To date, four vaccines have been approved by European …
SARS-CoV-2 variants B. 1.351 and B. 1.1. 248: Escape from therapeutic antibodies and antibodies induced by infection and vaccination
M Hoffmann, P Arora, R Groß, A Seidel, B Hörnich… - BioRxiv, 2021 - biorxiv.org
The global spread of SARS-CoV-2/COVID-19 is devastating health systems and economies
worldwide. Recombinant or vaccine-induced neutralizing antibodies are used to combat the …
worldwide. Recombinant or vaccine-induced neutralizing antibodies are used to combat the …
[HTML][HTML] BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA. 1 …
A Seidel, M Zanoni, R Groß, D Krnavek… - Frontiers in …, 2022 - frontiersin.org
In light of the decreasing immune protection against symptomatic SARS-CoV-2 infection
after initial vaccinations and the now dominant immune-evasive Omicron variants, ‘booster’ …
after initial vaccinations and the now dominant immune-evasive Omicron variants, ‘booster’ …
[HTML][HTML] Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad …
Besides pandemic SARS-CoV-2, also endemic seasonal human common cold coronaviruses
(hCoVs) have a significant impact on human health and economy. Studies on hCoVs and …
(hCoVs) have a significant impact on human health and economy. Studies on hCoVs and …
Severe acute respiratory syndrome coronavirus 2 vaccination boosts neutralizing activity against seasonal human coronaviruses
Background Most of the millions of people that are vaccinated against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 …
syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 …
Characterization of the SARS-CoV-2 neutralization potential of COVID-19–convalescent donors
B Jahrsdörfer, R Groß, A Seidel, L Wettstein… - The Journal of …, 2021 - journals.aai.org
The current SARS-CoV-2 pandemic has triggered the development of various SARS-CoV-2
neutralization tests. A wild-type virus (using African green monkey VeroE6 cells), a …
neutralization tests. A wild-type virus (using African green monkey VeroE6 cells), a …